Clinical trials continue to increase in complexity and scope. A typical
Phase III protocol, for example, now has many more endpoints,
procedures, and data points collected compared to a decade ago. At
the same time, data management processes are more complicated,
as CROs and sponsors manage a variety of clinical trial data.
Richard Young at Vault EDC Veeva Systems says that the real-world
evidence, electronic clinical outcome assessments, mobile devicedriven
data, social media communities, and electronic health and
medical records are examples of new data sources captured during
clinical trials.